Life and death of a cardiac myocyte: Principles of cellular biology

Perfusion

Volumn 16, Issue 3, 2001, Pages 229-241

  Basile Borgia, A E ^a   Ware, V C ^a  

^a LEHIGH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRTH; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELLULAR DISTRIBUTION; CLINICAL RESEARCH; CONTROLLED STUDY; CYTOLOGY; DEATH; EXTRACORPOREAL CIRCULATION; GENE EXPRESSION; GENE TRANSFER; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; LIFE; MOLECULAR GENETICS; MUSCLE DEVELOPMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0034990496     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910101600309     Document Type: Article

References (64)

1. Molecular therapies for vascular diseases
2. Molecular genetic insights into cardiovascular disease
3. Potential gene therapy strategies in the treatment of cardiovascular disease
4. Toward molecular strategies for heart disease: Past, present, future
5. Molecular advances in cardiac and cardiovascular disease
6. Biological catalysis by RNA
7. The chemistry of self-splicing RNA and RNA enzymes
8. Transcription factors and the cardiac gene programme
9. Cell cycle control in the terminally differentiated myocyte: A platform for myocardial repair?
10. Regulation of myocardial cell growth and multiplication
11. Transcriptional regulation during cardiac growth and development
12. Vertebrate heart development
13. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF-2) proteins
14. Factors involved in cardiogenesis and the regulation of cardiac-specific gene expression
15. Induction of visceral and cardiac mesoderm by ectodermal Dpp in the early Drosophila embryo
16. Evolution of the ventricles
17. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
18. Nitric oxide release accounts for the biological activity of endothelial-derived relaxation factor
19. Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system: Potential targets for therapy?
20. Arresting developments in the cardiac myocyte cell cycle: Role of cyclin-dependent kinase inhibitors
21. Myocardial infarction as a problem of growth control: Cell cycle therapy for cardiac myocytes
22. Cardiac myocyte terminal differentiation: Potential for cardiac regeneration
23. Potential approaches for myocardial regeneration
24. Molecular and cellular prospects for repair, augmentation, and replacement of the failing heart
25. MEF2: A transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation
26. Apoptosis in the failing heart
27. Death by design: Programmed cell death in cardiovascular biology and disease
28. Apoptosis in human acute myocardial infarction
29. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat
30. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure
31. The MADS-box family of transcription factors
32. Characterization of a promoter element required for transcription in myocardial cells
33. A novel, tissue restricted zinc finger protein (HF-1b) binds to the cardiac regulatory element (HF-1b/MEF-2) in the rat myosin light chain-2 gene
34. Regulatory mechanisms for skeletal muscle differentiation and their relevance to gene expression in the heart
35. Muscle differentiation: More complexity to the network of myogenic regulators
36. Myogenic regulatory factors: Dissecting their role and regulation during vertebrate embryogenesis
37. Cardiac endothelium and tissue growth
38. Early steps in vertebrate cardiogenesis
39. Cultured adult cardiac myocytes: Future applications, culture methods, morphological and electrophysiological properties
40. Cellular cardiomyoplasty: Results and possibilities for the future
41. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium
42. Survival, integration, and differentiation of cardiomyocytes grafts
43. Gene transfer approaches for cardiovascular disease
44. Arresting developments in the cardiac myocyte cell cycle: Role of cyclin-dependent kinase inhibitors
45. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical trials of a new treatment of coronary heart disease
46. Tumor angiogenesis: Therapeutic implications
47. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice
48. Current techniques of hyperthermic isolated limb perfusion for malignant melanoma
49. Therapeutic hyperthermia
50. Heparin-mediated extracorporeal LDL/fibrinogen precipitation - H.E.L.P. - In coronary and cerebral ischemia
51. Extracorporeal removal of proinflammatory cytokines by specific absorption onto microspheres
52. Isolated lung liposome-mediated gene transfer produces organ-specific transgenic expression
53. Isolated-organ perfusion for local gene delivery: Efficient adenovirus-mediated gene transfer into the liver
54. Ultrarapid, highly efficient viral gene transfer to the heart
55. Adenovirus-mediated gene transfer into rat cardiac allografts. Comparison of direct injection and perfusion
56. Gene transfer into rat heart-derived endothelial cells
57. Gene therapy for donor hearts: Ex vivo liposome-mediated transfection
58. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - First steps towards gene therapy of Alport syndrome
59. Factors influencing hepatocyte trafficking during allogeneic hepatocyte transplantation: Improved liver sequestration with isolated perfusion